Shares of CVS Health Corp tumbled on Friday with other drugstore chains following a report that it could acquire insurer Aetna Inc to fortify itself against a possible Amazon Inc entry into the sector.
CVS Health has offered to buy Aetna for more than US$200 per share, the Wall Street Journal reported late on Thursday, citing people familiar with the matter.
The newspaper described the talks as serious, but said they might not lead to a deal.
Shares of CVS Health lost 5.9 percent, while Aetna dropped 3.9 percent.
A merger of CVS and Aetna would create a healthcare behemoth and put huge pressure on standalone players such as Express Scripts Holding Co and Walgreens Boots Alliance Inc. Express Scripts would become the last major standalone pharmacy-benefit manager (PBM) not allied with a major insurer.
Under a combined roof, the insurance arm of CVS-Aetna could help keep costs down by routing patients needing basic urgent care to CVS-owned walk-in clinics and keeping them out of expensive hospital emergency rooms, Mizuho Securities Co analyst Ann Hynes said in a note to clients.
The company would also become a formidable competitor to UnitedHealth Group Inc, the biggest health insurer and owner of its own PBM unit, OptumRx.
CVS and Aetna declined to comment.
The possible deal comes amid signs that Amazon.com Inc is preparing to expand into pharmacy distribution.
A report in the St Louis Post-Dispatch said Amazon, which has disrupted the grocery business with its US$13.7 billion acquisition of Whole Foods Market Inc, had obtained licenses in 12 states to become a wholesale pharmaceutical distributor.
“While these licenses do not seemingly permit [Amazon] to act as a dispensing pharmacy, it does allow it to deliver relevant pharmaceutical and medical products to pharmacies,” Credit Suisse Group AG said in a note.
“We can only speculate as to what Amazon’s next steps may be,” the note added. “While we acknowledge the inherent challenges and complexities of the supply chain, the specter of Amazon continues to weigh on sentiment across our universe of distributors, pharmacies, and [pharmacy benefit managers].”
CFRA Research analyst Joe Agnese said Amazon’s move was the “big threat for the sector right now.”
Additional reporting by Bloomberg
DIVERSIFICATION: The chip designer expects new non-smartphone products to be available next year or in 2025 as it seeks new growth engines to broaden its portfolio MediaTek Inc (聯發科) yesterday said it expects non-mobile phone chips, such as automotive chips, to drive its growth beyond 2025, as it pursues diversification to create a more balanced portfolio. The Hsinchu-based chip designer said it has counted on smartphone chips, power management chips and chips for other applications to fuel its growth in the past few years, but it is developing new products to continue growing. “Our future growth drivers, of course, will be outside of smartphones,” MediaTek chairman Rick Tsai (蔡明介) told shareholders at the company’s annual general meeting in Hsinchu City. “As new products would be available next year
At a red-brick factory in the German port city of Hamburg, cocoa bean shells go in one end and out the other comes an amazing black powder with the potential to counter climate change. The substance, dubbed biochar, is produced by heating the cocoa husks in an oxygen-free room to 600°C. The process locks in greenhouse gases and the final product can be used as a fertilizer, or as an ingredient in the production of “green” concrete. While the biochar industry is still in its infancy, the technology offers a novel way to remove carbon from the Earth’s atmosphere, experts have said. Biochar could
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) shares yesterday rallied 2 percent on the local stock market after Nvidia Corp said the contract chipmaker would be the sole supplier of its latest graphics processing chip, defusing speculation that Intel Corp would get a share of the orders. TSMC’s share price climbed to NT$562, snapping a three-day losing streak. It outperformed the benchmark index’s 1.18 percent gain. Net purchases by foreign institutional investors yesterday totaled 8.37 million shares, reversing net sales of 2.9 million shares on Thursday. The rebound follows Nvidia’s announcement that its latest artificial intelligence graphics processing unit (GPU), codenamed H100, would
Taiwan is expected to be the third-largest market for Singapore-based DBS Group Holdings Ltd, after DBS Bank Taiwan (星展台灣) completes its acquisition of Citibank Taiwan Ltd’s (台灣花旗) consumer banking business in August, a bank executive said yesterday. Taiwan would rank after only Singapore and Hong Kong in terms of profit contribution to DBS, followed by China, India and Indonesia, DBS Taiwan general manager Ng Sier Han (黃思翰) told a media briefing in Taipei. DBS Bank Taiwan expects to retain all 2.77 million Citibank Taiwan cardholders and help them to transition to DBS Taiwan cards over the next 12 months, Ng said. The bank